Werewolf Therapeutics, Inc.

JPMORGAN CHASE & CO HOWL

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

2,072

Value ($000)

1

Weight

0.0%

2021 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	1	0.0%	2,072	12/31/2025
2025 Q3	11/7/2025	2	0.0%	1,123	9/30/2025
2025 Q2	8/12/2025	12	0.0%	10,898	6/30/2025
2025 Q1	5/12/2025	16	0.0%	16,012	3/31/2025
2024 Q4	2/12/2025	93	0.0%	62,928	12/31/2024
2024 Q3	11/8/2024	28	0.0%	13,320	9/30/2024
2024 Q2	8/12/2024	32	0.0%	13,075	6/30/2024
2024 Q1	5/10/2024	461	0.0%	71,184	3/31/2024
2023 Q4	2/12/2024	0	0.0%	83	12/31/2023
2023 Q3	11/14/2023	2	0.0%	748	9/30/2023
2023 Q2	8/11/2023	2	0.0%	748	6/30/2023
2023 Q1	5/18/2023	2	0.0%	748	3/31/2023
2022 Q4	2/13/2023	2	0.0%	748	12/31/2022
2022 Q3	11/14/2022	7	0.0%	1,500	9/30/2022
2022 Q2	8/11/2022	15	0.0%	3,698	6/30/2022
2022 Q1	5/11/2022	68	0.0%	15,627	3/31/2022
2021 Q4	2/11/2022	334	0.0%	28,057	12/31/2021
2021 Q3	11/12/2021	66	0.0%	3,848	9/30/2021
2021 Q2	8/12/2021	163	0.0%	9,352	6/30/2021